These observations together with the correlation between high anti-HisRS-FL antibody levels in circulation and the presence of ILD support the previously raised hypothesis that the lung might be a site where aberrant immune activation against HisRS primarily occurs, leading to a systemic inflammatory condition, the anti-synthetase syndrome, with ILD as the main clinical manifestation. The gene discussed is FLT3LG; the disease is interstitial lung disease.